explore -WSS

explore

author：leisure time 2025-08-23 08:54:29 - browse：426

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

WSS

Security flaws in third

Canadians with cystic fibrosis outlive Americans by a decade

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Canadians with cystic fibrosis outlive Americans by a decade

'Screen and refer' systems are hurting patients

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

knowledge

explore

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Crowdfunding for unproven stem cell procedures spreads misinformation

Virginia high school admissions case could be legal follow

How Robert F. Kennedy Jr. distorted vaccine science

Apple is now the first public company to be valued at $3 trillion

NIH nominee Bertagnolli will get October confirmation hearing

Duchenne breakthrough therapy leaves behind pioneering families

'Make People Better': The CRISPR babies story you probably don't know

Sports medicine is finally prioritizing gender equality

Why Novartis is changing the name of its research labs

focus

How Robert F. Kennedy Jr. distorted vaccine science

ALS advocates say criticism of new drugs misses bigger picture

The (many) problems with a new study criticizing cancer screening

Crowdfunding for unproven stem cell procedures spreads misinformation

Listen: Biogen's potential pivot, & Illumina's next chapter

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Wikipedia

explore

explore

leisure time